Article

Cryotherapy may result in sympathetic ophthalmia

Cryotherapy applied to treat retinal holes may be associated with the development of sympathetic ophthalmia.

Key Points

A fundus examination through dilated pupils showed a retinal detachment associated with one round hole inferotemporally in the right eye. Cryotherapy with scleral buckle attachment was performed in the right eye. The patient did well in the immediate postoperative period.

Two months postoperatively, she returned with bilateral blurring of the vision. The visual acuities were 20/20 and 20/120 in the right and left eyes, respectively, resulting from macular edema and bilateral granulomatous panuveitis with choroidal thickening, confirmed by ultrasonography.

Three months after the onset of uveitis, the bilateral visual acuities were 20/20, Dr. Chandra reported.

"Sympathetic ophthalmia usually results from penetrating injury to the uveal tissue. In the UK, the estimate is that three out of 10 million penetrating injuries might result in sympathetic ophthalmia, but that incidence is uncertain," he said.

A few reports in the literature have described sympathetic ophthalmia resulting from laser cyclodestructive procedures, Dr. Chandra said, adding, however, that up to this time there have been no reports after the use of cryotherapy to treat a retinal hole.

"The initial pathology in this case beyond the subconjunctival hemorrhage was the incidentally found retinal detachment, which is usually associated with round holes. The incidence of these is poorly defined. The management is very difficult.

"In the United Kingdom, a recent survey reported that from 9% to 94% of retinal surgeons will do surgery depending on the position of the detachment, demarcation lines, the type of hole, and vitreous detachment. Because of the lack of guidelines, it is difficult for retinal surgeons to decide which course to take," he said.

"This patient was, in fact, very fortunate to obtain a very good visual outcome, and it reminds us of what Hippocrates instructed us over a millennium ago: First, do no harm," Dr. Chandra said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.